Shilpa Medicare gets USFDA approval for cancer treatment injection

Shilpa Medicare said the US market for Irinotecan HCL is approximately $18 million

from Latest News http://bit.ly/2EYsciU
https://ift.tt/eA8V8J http://bit.ly/2SdCH5P

• Tweet
• Share
• Share
• Share
• Share